Neuronetics Historical Income Statement

STIM Stock

USD 2.33 0.02 0.85%

Historical analysis of Neuronetics income statement accounts such as Selling And Marketing Expenses of 41.1 M, Total Revenue of 59.3 M, Gross Profit of 45.2 M or Other Operating Expenses of 84.8 M can show how well Neuronetics performed in making a profits. Evaluating Neuronetics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Neuronetics's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Neuronetics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Neuronetics is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.

About Neuronetics Income Statement Analysis

Neuronetics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Neuronetics shareholders. The income statement also shows Neuronetics investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Neuronetics Income Statement Chart

At this time, Neuronetics' Total Other Income Expense Net is very stable compared to the past year. As of the 23rd of January 2025, Non Operating Income Net Other is likely to grow to about 2.7 M, while Net Interest Income is likely to drop (5.1 M).

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit

Total Revenue

Total revenue comprises all receipts Neuronetics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Neuronetics minus its cost of goods sold. It is profit before Neuronetics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Neuronetics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Neuronetics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.At this time, Neuronetics' Total Other Income Expense Net is very stable compared to the past year. As of the 23rd of January 2025, Non Operating Income Net Other is likely to grow to about 2.7 M, while Net Interest Income is likely to drop (5.1 M).

	2024	2025 (projected)
Depreciation And Amortization	2.3M	1.4M
Interest Income	4.2M	3.3M

Depreciation And Amortization Interest Income

Neuronetics income statement Correlations

	Net Interest Income	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Reconciled Depreciation	Non Operating Income Net Other
Net Interest Income		-0.93	-0.72	-0.96	-0.92	-0.91	-0.91	-0.91	-0.92	0.93	0.92	0.87	-0.51	0.87	-0.9	-0.92	0.92	0.32	0.88	0.11	-0.84	-0.81
Interest Income	-0.93		0.74	0.94	0.91	0.93	0.92	0.92	0.93	-0.91	-0.93	-0.91	0.55	-0.91	0.9	0.93	-0.93	-0.44	-0.92	0.05	0.79	0.73
Depreciation And Amortization	-0.72	0.74		0.77	0.77	0.86	0.89	0.89	0.87	-0.79	-0.73	-0.74	0.9	-0.71	0.88	0.86	-0.73	-0.12	-0.72	0.01	0.82	0.81
Interest Expense	-0.96	0.94	0.77		0.94	0.94	0.96	0.95	0.96	-0.89	-0.87	-0.83	0.52	-0.82	0.96	0.95	-0.87	-0.29	-0.83	-0.13	0.92	0.78
Selling General Administrative	-0.92	0.91	0.77	0.94		0.94	0.95	0.96	0.97	-0.95	-0.93	-0.91	0.49	-0.9	0.91	0.97	-0.93	-0.37	-0.9	-0.03	0.91	0.89
Selling And Marketing Expenses	-0.91	0.93	0.86	0.94	0.94		0.99	0.99	0.99	-0.95	-0.92	-0.9	0.63	-0.89	0.97	0.99	-0.92	-0.2	-0.87	-0.15	0.92	0.87
Total Revenue	-0.91	0.92	0.89	0.96	0.95	0.99		1.0	1.0	-0.92	-0.88	-0.86	0.65	-0.84	0.99	0.99	-0.88	-0.17	-0.83	-0.16	0.95	0.87
Gross Profit	-0.91	0.92	0.89	0.95	0.96	0.99	1.0		1.0	-0.93	-0.9	-0.88	0.65	-0.87	0.98	0.99	-0.9	-0.21	-0.85	-0.14	0.94	0.89
Other Operating Expenses	-0.92	0.93	0.87	0.96	0.97	0.99	1.0	1.0		-0.95	-0.92	-0.9	0.63	-0.89	0.98	1.0	-0.92	-0.24	-0.88	-0.11	0.94	0.89
Operating Income	0.93	-0.91	-0.79	-0.89	-0.95	-0.95	-0.92	-0.93	-0.95		0.99	0.98	-0.57	0.97	-0.87	-0.96	0.99	0.39	0.96	-0.01	-0.83	-0.89
Net Income From Continuing Ops	0.92	-0.93	-0.73	-0.87	-0.93	-0.92	-0.88	-0.9	-0.92	0.99		0.99	-0.53	0.99	-0.83	-0.93	1.0	0.51	0.99	-0.1	-0.76	-0.82
Ebit	0.87	-0.91	-0.74	-0.83	-0.91	-0.9	-0.86	-0.88	-0.9	0.98	0.99		-0.55	1.0	-0.8	-0.92	0.99	0.52	0.99	-0.15	-0.73	-0.82
Research Development	-0.51	0.55	0.9	0.52	0.49	0.63	0.65	0.65	0.63	-0.57	-0.53	-0.55		-0.52	0.65	0.63	-0.53	-0.15	-0.56	0.2	0.52	0.58
Ebitda	0.87	-0.91	-0.71	-0.82	-0.9	-0.89	-0.84	-0.87	-0.89	0.97	0.99	1.0	-0.52		-0.78	-0.91	0.99	0.54	0.99	-0.16	-0.72	-0.8
Cost Of Revenue	-0.9	0.9	0.88	0.96	0.91	0.97	0.99	0.98	0.98	-0.87	-0.83	-0.8	0.65	-0.78		0.96	-0.83	-0.1	-0.77	-0.21	0.96	0.83
Total Operating Expenses	-0.92	0.93	0.86	0.95	0.97	0.99	0.99	0.99	1.0	-0.96	-0.93	-0.92	0.63	-0.91	0.96		-0.93	-0.28	-0.89	-0.09	0.93	0.89
Income Before Tax	0.92	-0.93	-0.73	-0.87	-0.93	-0.92	-0.88	-0.9	-0.92	0.99	1.0	0.99	-0.53	0.99	-0.83	-0.93		0.51	0.99	-0.1	-0.76	-0.82
Total Other Income Expense Net	0.32	-0.44	-0.12	-0.29	-0.37	-0.2	-0.17	-0.21	-0.24	0.39	0.51	0.52	-0.15	0.54	-0.1	-0.28	0.51		0.61	-0.73	-0.03	-0.11
Net Income	0.88	-0.92	-0.72	-0.83	-0.9	-0.87	-0.83	-0.85	-0.88	0.96	0.99	0.99	-0.56	0.99	-0.77	-0.89	0.99	0.61		-0.24	-0.7	-0.78
Income Tax Expense	0.11	0.05	0.01	-0.13	-0.03	-0.15	-0.16	-0.14	-0.11	-0.01	-0.1	-0.15	0.2	-0.16	-0.21	-0.09	-0.1	-0.73	-0.24		-0.32	-0.11
Reconciled Depreciation	-0.84	0.79	0.82	0.92	0.91	0.92	0.95	0.94	0.94	-0.83	-0.76	-0.73	0.52	-0.72	0.96	0.93	-0.76	-0.03	-0.7	-0.32		0.85
Non Operating Income Net Other	-0.81	0.73	0.81	0.78	0.89	0.87	0.87	0.89	0.89	-0.89	-0.82	-0.82	0.58	-0.8	0.83	0.89	-0.82	-0.11	-0.78	-0.11	0.85

Click cells to compare fundamentals

Neuronetics Account Relationship Matchups

Neuronetics income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Net Interest Income	(4.5M)	(4.0M)	(4.3M)	(5.4M)	(4.9M)	(5.1M)
Depreciation And Amortization	941K	1.1M	1.6M	2.0M	2.3M	1.4M
Interest Expense	4.5M	4.0M	4.3M	5.4M	6.2M	4.2M
Selling General Administrative	18.2M	25.6M	25.5M	25.4M	29.2M	19.4M
Selling And Marketing Expenses	32.6M	37.7M	50.0M	47.3M	54.4M	41.1M
Total Revenue	49.2M	55.3M	65.2M	71.3M	82.1M	59.3M
Gross Profit	37.7M	43.7M	49.7M	51.7M	59.5M	45.2M
Other Operating Expenses	71.6M	82.9M	100.3M	101.9M	117.2M	84.8M
Operating Income	(22.3M)	(27.6M)	(35.1M)	(30.6M)	(27.5M)	(28.9M)
Net Income From Continuing Ops	(27.5M)	(31.2M)	(37.2M)	(30.2M)	(27.1M)	(28.5M)
Ebit	(22.0M)	(27.6M)	(32.9M)	(24.8M)	(22.3M)	(23.4M)
Research Development	9.2M	7.9M	9.3M	9.5M	10.9M	10.2M
Ebitda	(21.1M)	(26.6M)	(31.3M)	(22.8M)	(20.5M)	(21.5M)
Cost Of Revenue	11.6M	11.7M	15.5M	19.6M	22.6M	14.1M
Total Operating Expenses	60.0M	71.2M	84.8M	82.3M	94.6M	70.7M
Income Before Tax	(27.5M)	(31.2M)	(37.2M)	(30.2M)	(27.2M)	(28.5M)
Total Other Income Expense Net	(5.1M)	(3.6M)	(2.0M)	365K	328.5K	344.9K
Net Income Applicable To Common Shares	(29.0M)	(27.5M)	(31.2M)	(37.2M)	(33.4M)	(35.1M)
Net Income	(32.3M)	(35.6M)	(39.2M)	(30.2M)	(27.2M)	(28.5M)
Income Tax Expense	4.8M	4.4M	2.0M	(24K)	(21.6K)	(20.5K)
Reconciled Depreciation	941K	1.1M	1.6M	2.0M	2.3M	1.3M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Neuronetics is a strong investment it is important to analyze Neuronetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuronetics' future performance. For an informed investment choice regarding Neuronetics Stock, refer to the following important reports:

How To Invest In Neuronetics

Details

Is Neuronetics Stock a good investment?

Details

What is Neuronetics' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.

You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.28)

Revenue Per Share

2.453

Quarterly Revenue Growth

(0.07)

Return On Assets

(0.17)

Return On Equity

(1.00)

The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Neuronetics Historical Income Statement

About Neuronetics Income Statement Analysis

Neuronetics Income Statement Chart

Total Revenue

Gross Profit

Neuronetics income statement Correlations

Neuronetics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Neuronetics income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Gross Profit
Total Operating Expenses	+ 1.0	Other Operating Expenses
Income Before Tax	+ 1.0	Net Income From Continuing Ops
Ebitda	+ 1.0	Ebit

Total Operating Expenses	- 0.96	Operating Income
Interest Expense	- 0.96	Net Interest Income
Operating Income	- 0.95	Other Operating Expenses
Operating Income	- 0.95	Selling And Marketing Expenses
Operating Income	- 0.95	Selling General Administrative
Income Before Tax	- 0.93	Total Operating Expenses